NGM Biopharmaceuticals In...

NASDAQ: NGM · Real-Time Price · USD
1.54
-0.02 (-1.28%)
At close: Apr 03, 2024, 3:59 PM

NGM Biopharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.5 -2.52 -11.99
PEG Ratio
0.04 -0.07 -1.49
PS Ratio
16.04 7.25 17.53
PB Ratio
0.48 1.55 4.07
P/FCF Ratio
-0.53 -2.74 -18.22
P/OCF Ratio
-0.54 -2.78 -18.64
OCF/S Ratio
-29.93 -2.61 -0.94
Debt / Equity Ratio
n/a 0.02 0.03
Quick Ratio
7.79 6.04 6.18
Current Ratio
7.79 6.04 6.18
Asset Turnover
0.03 0.18 0.19
Interest Coverage
n/a -44.76 n/a
Return on Equity
-0.96 -0.61 -0.34
Return on Assets
-0.84 -0.52 -0.28
Return on Invested Capital
-0.98 -0.61 -0.33
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.50 0.89 0.90
Net Profit Margin
-32.23 -2.88 -1.46
Pretax Profit Margin
-32.23 -2.94 -1.55
Operating Profit Margin
-33.18 -3 -1.55
FCF Margin
n/a n/a n/a
EBITDA Margin
-32.68 -3 -1.55